Zeposia

Zeposia (ozanimod) is a prescription medication used to treat Ulcerative colitis and multiple sclerosis. A once-daily oral capsule, advertised mainly for moderate-to-severe ulcerative colitis and also approved for relapsing forms of multiple sclerosis.

An S1P receptor modulator that keeps certain immune cells in the lymph nodes, reducing the inflammation that damages the gut or nerves.

Commonly reported side effects of Zeposia include Increased infection risk, Slowed heart rate, High blood pressure, Liver enzyme changes, and Headache. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Zeposia has notable warnings and precautions. Tell your doctor about your medical history and any other medicines or supplements you take before starting Zeposia.

The active ingredient in Zeposia is ozanimod, which belongs to a class of medicines known as S1P Receptor Modulator.

Zeposia is manufactured by Bristol Myers Squibb. It was first approved in 2020.

You may be able to lower the cost of Zeposia by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.